ObaCell potential Obatala Sciences offers ObaCell, a fat tissue model with obesity and diabetes relevance, suggesting strong sales opportunities for contract research, obesity-on-a-chip studies, and metabolic disease research collaborations with pharma, academia, and government clients.

Growth momentum Recent recognition as Small Business of the Year and multiple launches indicate a growing market presence and credibility that can be leveraged to pursue strategic partnerships, sponsored research, and contract opportunities.

Joint ventures With capabilities spanning proteomics, genomics, adipokine secretion, and white/brown fat tissue formation, there are cross-sell possibilities for CRO services, data analytics, and custom model development for client drug screening and mechanism studies.

Leverage networks A diverse client base including major pharma, government entities, CROs, and academia points to multi-channel outreach opportunities via government grants, consortiums, and sponsored research collaborations.

Funding readiness Current revenue and $3M funding position Obatala to engage in larger-scale projects, pilot programs, and scalable service offerings that align with customer demand for human-relevant adipose tissue models and high-throughput screening.